On Thursday 11 September, Medilink Midlands was honoured to receive the Outstanding Contribution to Life Sciences Award at the Life Sciences Gala Dinner & Awards, part of Life Sciences Week 2025 – a week-long programme of events celebrating the region’s life sciences excellence. The Gala Dinner brought together organisations and...
Medilink Midlands Innovation Day 2025: Life sciences community unites at Villa Park
Medilink Midlands has celebrated another hugely successful Innovation Day, the Midlands' flagship life sciences and medtech conference and exhibition. Held on Wednesday 17 September at Villa Park, Birmingham, the event brought together over 250 delegates for a full day of sector insight, networking, exhibitions, and expert-led workshops. As part of...
WMHTC announces leadership transition and ownership transfer to Medilink Midlands
WMHTC today announced a significant transition in its leadership and ownership structure. The current Executive Chair of WMHTC, David Kidney, will be stepping down, marking the end of a pivotal chapter in the organisation’s journey. Effective 1 October 2025, WMHTC will be operated under the stewardship of Medilink Midlands. This...
Derby based Pennine healthcare hosts government whip to showcase ROTL success and future industry opportunities
Pennine Healthcare, one of the UK’s leading employee-owned medical device manufacturers, was proud to welcome Sir Nicholas Dakin, Government Whip, Lord Commissioner of HM Treasury, and Parliamentary Under-Secretary (Ministry of Justice), to its Derby headquarters last week. The visit highlighted the success of Pennine’s Release on Temporary Licence (ROTL) Scheme,...
Upperton win Pharma Contract Services Company of the Year at the Pharma Industry Awards UK 2025
Nottingham, UK – 11th September 2025 – Upperton Pharma Solutions has added another impressive award to a growing list of achievements, winning the award for Pharma Contract Services Company of the Year at the Pharma Industry Awards UK and nominated finalist for Pharma Company of the Year. This year marks...
Health Innovation East Midlands and Medilink Midlands confirm renewed collaboration to drive life sciences and innovation
Health Innovation East Midlands and Medilink Midlands are delighted to confirm the signing of a renewed Memorandum of Understanding, marking a strengthened collaboration to drive life sciences and health innovation across the East Midlands. Together, we will develop a joint proposition for consideration by the East Midlands Combined Authority and...
Haughton Design Appoints Dr Ash Ghadar as CEO to Accelerate Growth in Pharma and MedTech
Haughton Design, a leading UK-based product design consultancy specialising in medical devices, drug delivery systems and healthcare technology, has appointed Dr Ash Ghadar as Chief Executive Officer (CEO) to lead the company’s next phase of growth in the MedTech and Pharmaceutical sectors. Dr Ghadar joined Haughton Design in January 2025 as...
Pioneer and AbbVie team up on a Golden Ticket to accelerate game-changing innovations in human health
Pioneer Group, a specialist in life science infrastructure and venture building, has once again teamed up with global biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and...
TBAT Innovation Joins the Dains Group to Expand R&D and Innovation Services Nationwide
We’re proud to announce that TBAT Innovation has officially joined the Dains Group, one of the UK’s fastest-growing accountancy and advisory firms. This exciting development marks a significant milestone in TBAT’s journey and opens a new chapter of growth and enhanced service delivery. Founded in 2002, TBAT Innovation has spent over...
New Accelerator Programme to drive breakthroughs in managing chronic conditions
Pioneer Group, a specialist in life science infrastructure and venture building, has launched a new Accelerator Programme for early-stage life science companies targeting unmet needs in the management of chronic conditions. Funded by the Innovate UK Biomedical Catalyst, in collaboration with the Medical Research Council, the Accelerator has been designed...









